THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Graham Capital Management, L.P.'s Holding History (CIK: 0001315421)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 10,296 Value ($000) $193 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 16,111 Value ($000) $235 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 19,372 Value ($000) $214 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 24,954 Value ($000) $223 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 36,364 Value ($000) $342 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 30,756 Value ($000) $248 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 28,559 Value ($000) $242 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 16,353 Value ($000) $147 Avg Close $9.27 Range $8.21 - $11.71
Q2 2023
Shares 14,662 Value ($000) $152 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 17,930 Value ($000) $195 Avg Close $10.57 Range $9.25 - $11.52